Primary Mitochondrial Disease & Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis & Treatment - Dr. Richard Frye - 4/19/19

June 08, 2020 • 01:09:16
Primary Mitochondrial Disease & Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis & Treatment - Dr. Richard Frye - 4/19/19
MitoAction Expert Series
Primary Mitochondrial Disease & Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis & Treatment - Dr. Richard Frye - 4/19/19

Jun 08 2020 | 01:09:16

/

Show Notes

Join MitoAction and Dr. Richard Frye to discuss the distinction between primary and secondary mitochondrial diagnosis. Some talking points will include:

  • Primary mitochondrial disease (PMD) is ideally diagnosed by a known or indisputably pathogenic mitochondrial or nuclear DNA mutation.
  • Secondary mitochondrial dysfunction (SMD) can be caused by genes encoding either function nor production of the oxphos proteins and accompanies many heriditary non-mitochondrial diseases.
  • Secondary mitochondrial dysfunction (SMD) can also be caused by enviornmental factors.
  • In the absence of the ability to diagnose a primary mitochondrial disease (PMD), mitochondrial dysfunction can be effectively treated with standard treatments for PMD.
  • When the etiology of mitochondrial dysfunction is unknown, re-evaluation for genetic and other causes should be revisited on a regular basis.

About The Speaker:

Dr. Richard Frye is a pediatric neurologist and Chief of the Division of Neurodevelopmental Disorders at Phoenix Children’s Hospital.  He received his MD/PhD from Georgetown University in 1998. He completed a residency in Pediatrics at the University of Miami, Residency in Child Neurology and Fellowship in Behavioral Neurology and Learning Disabilities at Harvard University/Children’s Hospital Boston and Fellowship in Psychology at Boston University. He holds board certifications in Pediatrics, and in Neurology with Special Competence in Child Neurology. Dr. Frye is a national leader in autism research. He has authored over 100 peer-reviewed publications and book chapters, and serves on several editorial boards of scientific and medical journals.

Other Episodes

Episode 0

June 08, 2020 • 01:01:43
Episode Cover

Help is on the Way - Mary Summers - 9/13/19

Mitochondrial Disease can impact in many ways both an individual and everyone who cares for them: Health care needs Emotional support Basic needs Community...

Listen

Episode 0

June 05, 2020 • 01:24:16
Episode Cover

Dysautonomia: Body Temperature, Heart Rate and More! - Dr. David Holtzman - 4/4/08

MitoAction welcomes Dr. David Holtzman to discuss “dysautonomia”. Dysautonomia is a failure of the autonomic nervous system to regulate certain body functions, such as...

Listen

Episode 0

June 08, 2020 • 00:42:32
Episode Cover

Understanding the New Recommendations on the Safety of Drug Use in Patients with a Primary Mitochondrial Disease - Dr. Amel Karaa - 2/28/20

“Understanding the New Recommendations on the Safety of Drug Use in Patients with a Primary Mitochondrial Disease” Clinical guidance is often sought when prescribing...

Listen